Found: 78
Select item for more details and to access through your institution.
Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and Stroke.
- Published in:
- Frontiers in Neurology, 2019, p. N.PAG, doi. 10.3389/fneur.2019.00493
- By:
- Publication type:
- Article
Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0832-2
- By:
- Publication type:
- Article
Oligomalt, a New Slowly Digestible Carbohydrate, Reduces Post-Prandial Glucose and Insulin Trajectories Compared to Maltodextrin across Different Population Characteristics: Double-Blind Randomized Controlled Trials in Healthy Individuals, People with Obesity, and People with Type 2 Diabetes
- Published in:
- Metabolites (2218-1989), 2024, v. 14, n. 8, p. 410, doi. 10.3390/metabo14080410
- By:
- Publication type:
- Article
Role of a Digital Clinical Decision–Support System in General Practitioners' Management of COPD in Norway.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 2327, doi. 10.2147/COPD.S319753
- By:
- Publication type:
- Article
Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort.
- Published in:
- International Journal of COPD, 2019, v. 14, p. 1639, doi. 10.2147/COPD.S194019
- By:
- Publication type:
- Article
Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care.
- Published in:
- Vascular Health & Risk Management, 2010, v. 6, p. 31
- By:
- Publication type:
- Article
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia.
- Published in:
- Vascular Health & Risk Management, 2009, v. 5, p. 121
- By:
- Publication type:
- Article
Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study.
- Published in:
- Diabetologia, 2021, v. 64, n. 6, p. 1235, doi. 10.1007/s00125-021-05393-8
- By:
- Publication type:
- Article
Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®.
- Published in:
- Diabetologia, 2018, v. 61, n. 7, p. 1522, doi. 10.1007/s00125-018-4630-2
- By:
- Publication type:
- Article
The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 3, p. 950, doi. 10.1111/dom.15392
- By:
- Publication type:
- Article
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA‐REG OUTCOME trial with a focus on Asia.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1886, doi. 10.1111/dom.14415
- By:
- Publication type:
- Article
Impact of polyvascular disease with and without co‐existent kidney dysfunction on cardiovascular outcomes in diabetes: A post hoc analysis of EMPA‐REG OUTCOME.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 5, p. 1173, doi. 10.1111/dom.14326
- By:
- Publication type:
- Article
Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 569, doi. 10.1111/dom.14254
- By:
- Publication type:
- Article
Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add‐on to metformin in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 425, doi. 10.1111/dom.14234
- By:
- Publication type:
- Article
Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo‐controlled CARMELINA® trial
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1062, doi. 10.1111/dom.13995
- By:
- Publication type:
- Article
FDA guidance on antihyperglyacemic therapies for type 2 diabetes: One decade later.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1073, doi. 10.1111/dom.13645
- By:
- Publication type:
- Article
Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1620, doi. 10.1111/dom.12962
- By:
- Publication type:
- Article
Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141085
- By:
- Publication type:
- Article
Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME<sup>®</sup> trial.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 209, doi. 10.1093/eurheartj/ehz621
- By:
- Publication type:
- Article
Low-dose CT coronary angiography for assessment of coronary artery disease in patients with type 2 diabetes--a cross-sectional study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Exenatide may aggravate moderate diabetic renal impairment: a case report.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Long-term follow-up of a hospital-based, multi-intervention programme in type 2 diabetes mellitus: impact on cardiovascular events and death.
- Published in:
- Journal of International Medical Research, 2017, v. 45, n. 5, p. 1535, doi. 10.1177/0300060517707674
- By:
- Publication type:
- Article
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.
- Published in:
- European Journal of Endocrinology, 2012, v. 166, n. 3, p. 503, doi. 10.1530/EJE-11-0864
- By:
- Publication type:
- Article
Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events.
- Published in:
- Cardiovascular Diabetology, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12933-015-0215-2
- By:
- Publication type:
- Article
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME).
- Published in:
- Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1475-2840-13-102
- By:
- Publication type:
- Article
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.
- Published in:
- Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 2, doi. 10.1186/1475-2840-13-28
- By:
- Publication type:
- Article
Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study.
- Published in:
- Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-126
- By:
- Publication type:
- Article
Determinants and prognostic implications ofCardiac Troponin T measured by a sensitiveassay in Type 2 Diabetes Mellitus.
- Published in:
- Cardiovascular Diabetology, 2010, v. 9, p. 52, doi. 10.1186/1475-2840-9-52
- By:
- Publication type:
- Article
Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects.
- Published in:
- 2008
- By:
- Publication type:
- Case Study
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME ®.
- Published in:
- Diabetes & Vascular Disease Research, 2020, v. 17, n. 6, p. 1, doi. 10.1177/1479164120975256
- By:
- Publication type:
- Article
Oxidative stress and endothelial dysfunction are associated with reduced cognition in type 2 diabetes.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 6, p. 577, doi. 10.1177/1479164119848093
- By:
- Publication type:
- Article
Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes & Vascular Disease Research, 2016, v. 13, n. 2, p. 119, doi. 10.1177/1479164115616901
- By:
- Publication type:
- Article
Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®).
- Published in:
- Diabetes & Vascular Disease Research, 2015, v. 12, n. 3, p. 164, doi. 10.1177/1479164115570301
- By:
- Publication type:
- Article
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials.
- Published in:
- Diabetes & Vascular Disease Research, 2015, v. 12, n. 2, p. 90, doi. 10.1177/1479164114559852
- By:
- Publication type:
- Article
Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trial.
- Published in:
- Diabetes & Vascular Disease Research, 2013, v. 10, n. 4, p. 289, doi. 10.1177/1479164112475102
- By:
- Publication type:
- Article
Activin A and cardiovascular disease in type 2 diabetes mellitus.
- Published in:
- Diabetes & Vascular Disease Research, 2012, v. 9, n. 3, p. 234, doi. 10.1177/1479164111431171
- By:
- Publication type:
- Article
Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial.
- Published in:
- Clinical Kidney Journal, 2021, v. 14, n. 9, p. 2136, doi. 10.1093/ckj/sfab104
- By:
- Publication type:
- Article
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial.
- Published in:
- Clinical Kidney Journal, 2021, v. 14, p. 226, doi. 10.1093/ckj/sfaa225
- By:
- Publication type:
- Article
Oral enzyme combination with bromelain, trypsin and the flavonoid rutoside reduces systemic inflammation and pain when used pre- and post-operatively in elective total hip replacement: a randomized exploratory placebo-controlled trial.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2023, p. 1, doi. 10.1177/1759720X231186875
- By:
- Publication type:
- Article
Development of a tool to predict the risk of incident heart failure in a general population: the HUNT for HF risk score.
- Published in:
- ESC Heart Failure, 2023, v. 10, n. 5, p. 2807, doi. 10.1002/ehf2.14390
- By:
- Publication type:
- Article
Defining the Role of Repaglinide in the Management of Type 2 Diabetes Mellitus: A Review.
- Published in:
- American Journal of Cardiovascular Drugs, 2007, v. 7, n. 4, p. 319, doi. 10.2165/00129784-200707050-00002
- By:
- Publication type:
- Article
Undiagnosed dysglycaemia and inflammation in cardiovascular disease.
- Published in:
- European Journal of Clinical Investigation, 2006, v. 36, n. 8, p. 544, doi. 10.1111/j.1365-2362.2006.01679.x
- By:
- Publication type:
- Article
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls 在2型糖尿病患者中通过综合超声心动图评估来鉴定确诊的糖尿病性心肌病：与体重相匹配的非糖尿病对照组进行的横截面比较研究
- Published in:
- Journal of Diabetes, 2015, v. 7, n. 6, p. 779, doi. 10.1111/1753-0407.12239
- By:
- Publication type:
- Article
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial.
- Published in:
- Journal of Diabetes, 2009, v. 1, n. 3, p. 182, doi. 10.1111/j.1753-0407.2009.00031.x
- By:
- Publication type:
- Article
Heart Rate Adjustments and Analysis of Recovery Patterns Improves Detection of Coronary Artery Disease in Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A168
- By:
- Publication type:
- Article